Gains in cancer survival at risk due to surge in multi-drug resistant superbugs
May 4, 2017
| By Mary Engel / Fred Hutch News Service
Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different microorganisms, posing a risk to society at large.
25 years after his death, infectious disease expert Dr. Joel Meyers honored at inaugural symposium in his name
June 7, 2016
| By Rachel Tompa / Fred Hutch News Service
What was once a one-person research program started by Dr. Joel Meyers in the mid-70s at Fred Hutch has now grown into the world’s largest group of infectious disease researchers at any cancer center. Today, these researchers study not only infections in cancer patients, but HIV, malaria, viruses that themselves cause cancer, and many more. Meyers' legacy will be honored next week at an inaugural symposium in his name.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.